These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 21147921)

  • 1. Loss of the type I interferon pathway increases vulnerability of mice to genital herpes simplex virus 2 infection.
    Conrady CD; Halford WP; Carr DJ
    J Virol; 2011 Feb; 85(4):1625-33. PubMed ID: 21147921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A sustained type I IFN-neutrophil-IL-18 axis drives pathology during mucosal viral infection.
    Lebratti T; Lim YS; Cofie A; Andhey P; Jiang X; Scott J; Fabbrizi MR; Ozantürk AN; Pham C; Clemens R; Artyomov M; Dinauer M; Shin H
    Elife; 2021 May; 10():. PubMed ID: 34047696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Susceptibility of CCR5-deficient mice to genital herpes simplex virus type 2 is linked to NK cell mobilization.
    Thapa M; Kuziel WA; Carr DJ
    J Virol; 2007 Apr; 81(8):3704-13. PubMed ID: 17267483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycoprotein G of herpes simplex virus 2 as a novel vaccine antigen for immunity to genital and neurological disease.
    Görander S; Harandi AM; Lindqvist M; Bergström T; Liljeqvist JÅ
    J Virol; 2012 Jul; 86(14):7544-53. PubMed ID: 22553328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Role for Interleukin-17 in Enhancing Type 1 Helper T Cell Immunity in the Female Genital Tract following Mucosal Herpes Simplex Virus 2 Vaccination.
    Bagri P; Anipindi VC; Nguyen PV; Vitali D; Stämpfli MR; Kaushic C
    J Virol; 2017 Dec; 91(23):. PubMed ID: 28956763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CXCL9 and CXCL10 expression are critical for control of genital herpes simplex virus type 2 infection through mobilization of HSV-specific CTL and NK cells to the nervous system.
    Thapa M; Welner RS; Pelayo R; Carr DJ
    J Immunol; 2008 Jan; 180(2):1098-106. PubMed ID: 18178850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The application of a plasmid DNA encoding IFN-alpha 1 postinfection enhances cumulative survival of herpes simplex virus type 2 vaginally infected mice.
    Härle P; Noisakran S; Carr DJ
    J Immunol; 2001 Feb; 166(3):1803-12. PubMed ID: 11160227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Herpes simplex virus type 2 virion host shutoff protein regulates alpha/beta interferon but not adaptive immune responses during primary infection in vivo.
    Murphy JA; Duerst RJ; Smith TJ; Morrison LA
    J Virol; 2003 Sep; 77(17):9337-45. PubMed ID: 12915549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HSV-1 targets lymphatic vessels in the eye and draining lymph node of mice leading to edema in the absence of a functional type I interferon response.
    Bryant-Hudson KM; Chucair-Elliott AJ; Conrady CD; Cohen A; Zheng M; Carr DJJ
    Am J Pathol; 2013 Oct; 183(4):1233-1242. PubMed ID: 23911821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progesterone increases susceptibility and decreases immune responses to genital herpes infection.
    Kaushic C; Ashkar AA; Reid LA; Rosenthal KL
    J Virol; 2003 Apr; 77(8):4558-65. PubMed ID: 12663762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T-cell-mediated mechanisms involved in resolution of genital herpes simplex virus type 2 (HSV-2) infection of mice.
    Milligan GN; Dudley-McClain KL; Young CG; Chu CF
    J Reprod Immunol; 2004 Apr; 61(2):115-27. PubMed ID: 15063634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A mouse model for studies of mucosal immunity to vaginal infection by herpes simplex virus type 2.
    Parr MB; Kepple L; McDermott MR; Drew MD; Bozzola JJ; Parr EL
    Lab Invest; 1994 Mar; 70(3):369-80. PubMed ID: 8145530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of mandibular lymph node integrity is associated with an increase in sensitivity to HSV-1 infection in CD118-deficient mice.
    Conrady CD; Thapa M; Wuest T; Carr DJ
    J Immunol; 2009 Mar; 182(6):3678-87. PubMed ID: 19265146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of transcriptional profiling to delineate the initial response of mice to intravaginal herpes simplex virus type 2 infection.
    Cherpes TL; Harvey SA; Phillips JM; Vicetti Miguel RD; Melan MA; Quispe Calla NE; Hendricks RL
    Viral Immunol; 2013 Jun; 26(3):172-9. PubMed ID: 23638732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estradiol regulates susceptibility following primary exposure to genital herpes simplex virus type 2, while progesterone induces inflammation.
    Gillgrass AE; Fernandez SA; Rosenthal KL; Kaushic C
    J Virol; 2005 Mar; 79(5):3107-16. PubMed ID: 15709030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. OASL1 deficiency promotes antiviral protection against genital herpes simplex virus type 2 infection by enhancing type I interferon production.
    Oh JE; Lee MS; Kim YJ; Lee HK
    Sci Rep; 2016 Jan; 6():19089. PubMed ID: 26750802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutrophils aid in protection of the vaginal mucosae of immune mice against challenge with herpes simplex virus type 2.
    Milligan GN
    J Virol; 1999 Aug; 73(8):6380-6. PubMed ID: 10400730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucosal innate and adaptive immune responses against herpes simplex virus type 2 in a humanized mouse model.
    Kwant-Mitchell A; Ashkar AA; Rosenthal KL
    J Virol; 2009 Oct; 83(20):10664-76. PubMed ID: 19656896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired induction of protective immunity by highly virulent herpes simplex virus type 2 in a murine model of genital herpes.
    Inagaki-Ohara K; Daikoku T; Goshima F; Nishiyama Y
    Arch Virol; 2000; 145(10):1989-2002. PubMed ID: 11087087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential roles of B cells and IFN-gamma-secreting CD4(+) T cells in innate and adaptive immune control of genital herpes simplex virus type 2 infection in mice.
    Harandi AM; Svennerholm B; Holmgren J; Eriksson K
    J Gen Virol; 2001 Apr; 82(Pt 4):845-853. PubMed ID: 11257190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.